Antimetabolites: all 8,294 studies that test it
Page 76 of 83. Open to participants first (1,149), then studies with results posted, then the rest; newest registration first within each.
- Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00058201Phase 3
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00058149Phase 3
- S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerWithdrawnNCT00057928Phase 3
- Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2
- Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell TransplantationCompletedNCT00057005Phase 1
- Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell AnemiaCompletedNCT00056433Phase 1
- Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00056095Phase 2
- Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00056030Phase 2
- Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinStatus unknownNCT00055965Phase 3
- Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00055874Phase 3
- S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNCT00055835Phase 2
- Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00055757Phase 2
- Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerTerminatedNCT00055432Phase 2
- Treatment of Hepatitis C in Hemophilic Patients With HIVCompletedNCT00055341Phase 2
- A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic CancerCompletedNCT00055250Phase 2
- Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsCompletedNCT00054977Phase 1
- Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerCompletedNCT00054873Phase 2
- Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder CancerStatus unknownNCT00054626Phase 3
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
- Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00054431Phase 2
- Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
- Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00054288Phase 1
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
- S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054054Phase 2
- Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerCompletedNCT00053820Phase 3
- Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerCompletedNCT00053807Phase 3
- Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDSCompletedNCT00053287Phase 2
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00053209Phase 2
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00053144Phase 1
- Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00053131Phase 2
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaStatus unknownNCT00053105Phase 1
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell LymphomaCompletedNCT00053092Phase 2
- Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00053027Phase 2
- Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00052689Phase 2
- Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNCT00052585Phase 2
- Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal CancerCompletedNCT00052559Phase 1
- Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00052338Phase 1
- LY317615 Plus Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00052273Phase 1
- A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
- Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal CancerTerminatedNCT00051688Phase 2
- Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian CancerTerminatedNCT00051584Phase 2
- ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.CompletedNCT00051506Phase 2
- ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.CompletedNCT00051493Phase 2
- Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
- Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerTerminatedNCT00049660Phase 2/3
- Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsTerminatedNCT00049608Phase 1
- Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaTerminatedNCT00049582Phase 1
- Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00049348Phase 2
- S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedCompletedNCT00049335Phase 2
- BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast CancerStatus unknownNCT00049244Phase 1
- S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00049179Phase 2
- Fludarabine in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00049075Phase 2
- Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic CancerCompletedNCT00047710Phase 1
- Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00047307Phase 1
- Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal CancerCompletedNCT00047112Phase 3
- Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00047047Phase 1
- Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaCompletedNCT00047021Phase 2
- Combination Chemotherapy in Treating Patients With Colon CancerStatus unknownNCT00046995Phase 3
- UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00045747Phase 2
- Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS LymphomaCompletedNCT00045539Phase 2
- Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNCT00045513Phase 1/2
- Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00044954Phase 2
- Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00044889Phase 2
- Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid TumorsTerminatedNCT00044785Phase 1
- Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected SubjectsCompletedNCT00043953Phase 2
- Study of Gelonin Purging of Autologous Stem Cells for TransplantationTerminatedNCT00043810Phase 1/2
- Decitabine Versus Supportive Care in Adults With Advanced-stage MDSCompletedNCT00043381Phase 3
- Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic SyndromeStatus unknownNCT00043134Phase 3
- Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT00043121Phase 1
- BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00043095Phase 1
- Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerCompletedNCT00042965Phase 2
- Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00042874Phase 1
- UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00042861Phase 1
- Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaTerminatedNCT00042796Phase 1
- A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.CompletedNCT00042679Phase 2
- Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) PatientsCompletedNCT00042354Phase 2
- Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)CompletedNCT00042341Phase 2
- Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)CompletedNCT00042016Phase 2
- Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)CompletedNCT00042003Phase 2
- Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)CompletedNCT00041990Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00041314Phase 2
- Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNCT00041106Phase 2
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00040859Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00039611Not applicable
- Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryStatus unknownNCT00039546Phase 3
- Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00039442Phase 2
- UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00039403Phase 1
- Gefitinib and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00039390Phase 1
- Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00039208Phase 2
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00039117Phase 1
- Hepatitis C Antiviral Resistance in African-AmericansCompletedNCT00038974Phase 3
- Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDSCompletedNCT00038831Phase 1/2
- Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
- Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
- Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple SclerosisCompletedNCT00037102Phase 4
- Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid ArthritisCompletedNCT00036153Phase 3
- A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel DiseaseCompletedNCT00035074Not applicable
- A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the UrotheliumCompletedNCT00035061Phase 2